TP53 and neoplasm: Bill et al. showed that MDM2 inhibition with SAR405838, a non-Nutlin small molecular inhibitor of MDM2, induced cell-cycle arrest and apoptosis in wild-type p53 human DDLPS tumor cells, which was associated with the enrichment of p53-mediated gene expression patterns.